Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy.

Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy.

BACKGROUND:Cancer causes significant morbidity and mortality among HIV patients in the US due to extended life expectancy with access to effective antiretroviral therapy. Low, detectable HIV RNA has been studied as a risk factor for adverse health outcomes, but its clinical impact on cancer risk rem...

Full description

Bibliographic Details
Main Authors: Jennifer S Lee, Stephen R Cole, Chad J Achenbach, Dirk P Dittmer, David B Richardson, William C Miller, Christopher Mathews, Keri N Althoff, Richard D Moore, Joseph J Eron, Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS)
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5988275?pdf=render

Internet

http://europepmc.org/articles/PMC5988275?pdf=render

Similar Items